AKT1 and hepatocellular carcinoma: It is noteworthy that, in HCC tissues, TREM2 can both activate the PI3K/Akt signaling pathway to promote tumor progression and inhibit tumor progression by inhibiting the PI3K/Akt/β-Catenin pathway.